THCBF - THC BioMed Intl Ltd. (CSE: THC / OTC: THCBF / FSE: TFHC) Transitioning to Cannabis 2.0 / Q1-FY2022 Critical
Fundamental Research Corp has issued a report entitled "THC BioMed Intl Ltd. (CSE: THC / OTC: THCBF / FSE: TFHC) Transitioning to Cannabis 2.0 / Q1-FY2022 Critical" and dated July 26, 2021. To read a summary of the key highlights, or to login and download the full analyst report (subscription needed), please visit:
https://www.researchfrc.com/thc-biomed-intl-ltd-cse-thc-otc-thcbf-fse-tfhc-transitioning-to-cannabis-2-0-q1-fy2022-critical/
https://www.researchfrc.com/thc-biomed-intl-ltd-cse-thc-otc-thcbf-fse-tfhc-transitioning-to-cannabis-2-0-q1-fy2022-critical/
For further details see:
THC BioMed Intl Ltd. (CSE: THC / OTC: THCBF / FSE: TFHC) Transitioning to Cannabis 2.0 / Q1-FY2022 Critical